Clinical, molecular imaging and biomarker concordance in the diagnosis of Alzheimer ’s disease and vascular dementia

Conclusion FDG PET brain findin gs were concordant with the CSF biomarkers (CSF Aβ42, Total tau and Tau/Aβ42 ratio) in Alzheimer’s disease and Haemostatic biomarkers (Plasma Fibrinogen and D dimer) in vascular dementia. In clinical and molecular imaging discordance, biomarkers help in making a reliable diagnosis which favours the clinical assessment.
Source: Australasian Medical Journal - AMJ - Category: Journals (General) Source Type: research